SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-124091
Filing Date
2022-12-02
Accepted
2022-12-02 16:05:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2231715-1_424b5.htm 424B5 479516
2 GRAPHIC lg_nrx-4clr.jpg GRAPHIC 44547
  Complete submission text file 0001104659-22-124091.txt   542108
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265492 | Film No.: 221441962
SIC: 2834 Pharmaceutical Preparations